Patrick Moss

Patrick E. Moss, Pharm.D.

Executive Vice President, Chief Commercial Officer

“Patients and their families are counting on us. When I wake up in the morning until I go to bed at night, they are on my mind. My role at Sarepta will always be so much more than just a job. The intense focus and passion I have is driven by doing what is best for patients.”

Patrick joined Sarepta in 2015 as director, specialty distribution & payer access. Over the course of his tenure at Sarepta, his role has expanded in responsibility and scope, including building Sarepta’s industry-leading market access, reimbursement, sales, and specialty distribution teams. Patrick was also instrumental in building the team that oversaw the launch of Sarepta’s 4 therapies to treat Duchenne, including its first commercial therapy, EXONDYS 51. In July 2025, he was named Sarepta’s executive vice president and chief commercial officer.

Patrick’s vast biotechnology experience includes facilitating coverage of some of the most important medicines our industry has developed and commercialized. A principled and trusted leader, Patrick’s philosophy is grounded in patient health, scientific rigor, and accountability. 

“Patients and their families are counting on us. When I wake up in the morning until I go to bed at night, they are on my mind. My role at Sarepta will always be so much more than just a job. The intense focus and passion I have is driven by doing what is best for patients.”

Patrick’s industry experience spans decades and includes roles at Incyte Corporation, Vertex Pharmaceuticals, Inc., Amgen Inc., and Eil Lilly & Company. 

He holds Bachelor of Science and Doctor of Pharmacy degrees from the St. Louis College of Pharmacy in St. Louis, MO. He also completed a Managed Care Pharmacy Residency with the University of Tennessee College of Pharmacy in Nashville, TN.